OTC · Medical - Specialties

Epigenomics AG (EPGNF) Stock

$1.12 +0.00% OTC: EPGNF Healthcare

Epigenomics AG is a molecular diagnostics company, which engages in the development and commercializing of proprietary products for the screening and diagnosis of cancer. It offers Epi proColon, a blood-based test for the early detection of colorectal cancer; Epi proLung, a confirmatory test that aids in the diagnosis of lung cancer, Epi BiSKit, a kit for the preparation of purified, bisulfite-converted DNA and, HCCBloodTest, a blood test for cirrhotic patients at high-risk for the development of hepatocellular carcinoma.

Valuation

MetricValue
Price$1.12
Market Cap$1.00M
P/E Ratio-0.05
P/B Ratio0.28
P/S Ratio1.26
EPS (TTM)$-0.36
52-Week High$1.12
52-Week Low$0.79
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-74.47%
ROA-75.85%
ROCE-111.81%
Gross Margin75.26%
Operating Margin-775.00%
Net Margin0.00%
Debt/Equity0.08
Current Ratio2.13

Annual Financials (USD)

Metric20212022202320242025
Revenue$6.0M$0$0$0$0
Operating Profit$-2.0M$-12.0M$-4.0M$-1.0M$0
Net Profit$-2.0M$-12.0M$-4.0M$-3.0M$0
EPS$-4.33$-14.78$-5.23$-3.82$-0.36
Op Margin-38.0%-2484.7%-1231.2%—-1400.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$25.0M$16.0M$13.0M$1.0M$0
Total Liabilities$3.0M$6.0M$21.0M$12.0M$12.0M
Cash$23.0M$10.0M$2.0M$1.0M$0
Borrowings$0$1.0M$12.0M$11.0M$11.0M

Latest News

OCBC seeks to speed up wealth client onboarding with agentic AI Reuters · Jul 29, 2026 Austria's 16th century bell foundry adds modern technology to keep the casting process alive Associated Press · Jul 29, 2026 UBS says second-quarter net profit up 17% to $2.8 billion AFP · Jul 29, 2026 CDNS Q2 Deep Dive: AI-Driven Solutions and Strategic Partnerships Fuel Growth StockStory · Jul 29, 2026 Comprinno Joins the OpenAI Partner Network as a Select Partner to Accelerate Enterprise AI Adoption PR Newswire · Jul 29, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-4.0M$-12.0M$-6.0M——
Investing Cash Flow$1.0M$-3.0M$0——
Financing Cash Flow$0$0$0——
Net Cash Flow$19.0M$-13.0M$-6.0M——
Free Cash Flow$-4.0M$-13.0M$-6.0M$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA0.76
FCF Yield-2185.58%
Quick Ratio2.12
Interest Coverage-92.70
Return 1Y0.00%
Return 3Y-72.68%
Return 5Y—

Ownership

Insiders Held29.25%
Institutions Held0.00%
Institutions Float Held0.01%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BMMJBody and Mind Inc. $0.00 — -0.11 $29537 0.00%
CHMEChina Medicine Corp. $0.02 +0.00% 0.18 $474241 0.00%
CHYPFHealth Logic Interactive Inc. $0.02 +0.00% -3.77 $165839 0.00%
NGMCNext Generation Management Corp. $0.10 +0.00% 0.00 $31163 0.00%
NSTMNovelStem International Corp. $0.01 +30.00% 0.24 $641322 0.00%

About Epigenomics AG

Epigenomics AG is a molecular diagnostics company, which engages in the development and commercializing of proprietary products for the screening and diagnosis of cancer. It offers Epi proColon, a blood-based test for the early detection of colorectal cancer; Epi proLung, a confirmatory test that aids in the diagnosis of lung cancer, Epi BiSKit, a kit for the preparation of purified, bisulfite-converted DNA and, HCCBloodTest, a blood test for cirrhotic patients at high-risk for the development of hepatocellular carcinoma. The company was founded by Oliver Schacht, Christian Piepenbrock, Kurt Berlin, Jörn Walter, and Ivo G. Gut in 1998 and is headquartered in Berlin, Germany.

Epigenomics AG is headquartered in DE.

Epigenomics AG (EPGNF) stock trades at $1.12 with a market capitalization of $1.00M. The stock is valued at a price-to-earnings (P/E) ratio of -0.05, price-to-book of 0.28, price-to-sales of 1.26. Over the past 52 weeks the stock has ranged between $0.79 and $1.12, and currently trades at its 52-week high.

On profitability, Epigenomics AG generates a return on equity (ROE) of -74.47%, return on capital employed of -111.81%, an operating margin of -775.00%, a net profit margin of 0.00%.

Official website: www.epigenomics.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides